0002040590-24-000002.txt : 20241114 0002040590-24-000002.hdr.sgml : 20241114 20241114061358 ACCESSION NUMBER: 0002040590-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20241114 DATE AS OF CHANGE: 20241114 EFFECTIVENESS DATE: 20241114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PU-1002 Fund II, a series of CanCureLabs, LP CENTRAL INDEX KEY: 0002040590 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-529369 FILM NUMBER: 241456858 BUSINESS ADDRESS: STREET 1: 119 SOUTH MAIN STREET, SUITE 220 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 2068016359 MAIL ADDRESS: STREET 1: PO BOX 3217 CITY: SEATTLE STATE: WA ZIP: 98114 D 1 primary_doc.xml X0708 D LIVE 0002040590 PU-1002 Fund II, a series of CanCureLabs, LP 119 SOUTH MAIN STREET, SUITE 220 SEATTLE WA WASHINGTON 98104 2068016359 DELAWARE None None Limited Partnership true 2024 LLC Fund GP, 119 South Main Street, Suite 220 Seattle WA WASHINGTON 98104 Director General partner of the Issuer Ltd. Belltower Fund Group, 119 South Main St, Suite 220 Seattle WA WASHINGTON 98104 Director Agent of the general partner of the Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 false 2024-11-13 false true false 5000 325000 325000 0 false 10 0 0 0 This amount represents the dollar value of a one-time fee and an annual fee paid to the fund administrator and/or its affiliates to cover administrative expenses for the life of the fund. false PU-1002 Fund II, a series of CanCureLabs, LP /s/ Abraham Wilson Abraham Wilson Authorized Officer of the Agent of Issuer's GP 2024-11-14